Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
Annelies H BoekhoutA RogiersK JozwiakM J Boers-SonderenA J van den EertweghG A HospersJ W B de GrootM J B AartsE KapiteijnA J Ten TijeD PiersmaG VreugdenhilA A van der VeldtK P M SuijkerbuijkE A RozemanB NeynsK J JanssenL V van de Poll-FranseC U BlankPublished in: Acta oncologica (Stockholm, Sweden) (2020)
Compared to matched controls, long-term advanced melanoma survivors had overall worse functioning scores, more physical symptoms, and financial difficulties. These data may contribute to the development of appropriate survivorship care.